089140 — NexturnBioScience Co Cashflow Statement
0.000.00%
- KR₩38bn
- KR₩86bn
- KR₩41bn
Annual cashflow statement for NexturnBioScience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 6,918 | -3,430 | -3,997 | -4,448 | 9,681 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -325 | 1,902 | 3,489 | 2,161 | -7,219 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4,319 | 1,249 | 3,121 | -712 | -6,435 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2,735 | 236 | 3,664 | -1,191 | -1,971 |
Capital Expenditures | -7,454 | -57.2 | -487 | -282 | -1,082 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 5,801 | 73.8 | -72,764 | -56,229 | -16,335 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,653 | 16.6 | -73,251 | -56,511 | -17,417 |
Financing Cash Flow Items | 305 | — | -10.1 | -311 | 5,275 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -788 | -1,095 | 37,457 | 47,937 | 22,492 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -280 | -1,534 | -32,068 | -9,989 | 3,093 |